American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 859-867 , November 2008

Relations of Measures of Endothelial Function and Kidney Disease: The Framingham Heart Study

  • Meredith C. Foster, MPH

      Affiliations

    • The National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA
    • National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
    • ,
  • Michelle J. Keyes, PhD

      Affiliations

    • The National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA
    • ,
  • Martin G. Larson, ScD

      Affiliations

    • The National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA
    • ,
  • Joseph A. Vita, MD

      Affiliations

    • Cardiology Section, Boston University, Boston, MA
    • Whitaker Cardiovascular Institute School of Medicine, Boston University, Boston, MA
    • ,
  • Gary F. Mitchell, MD

      Affiliations

    • Cardiovascular Engineering Inc, Waltham, MA
    • ,
  • James B. Meigs, MD, MPH

      Affiliations

    • Harvard Medical School and Massachusetts General Hospital Division of General Internal Medicine, Boston, MA
    • ,
  • Ramachandran S. Vasan, MD

      Affiliations

    • The National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA
    • Cardiology Section, Boston University, Boston, MA
    • Whitaker Cardiovascular Institute School of Medicine, Boston University, Boston, MA
    • Preventive Medicine Section, Boston University, Boston, MA
    • ,
  • Emelia J. Benjamin, MD, ScM

      Affiliations

    • The National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA
    • Cardiology Section, Boston University, Boston, MA
    • Whitaker Cardiovascular Institute School of Medicine, Boston University, Boston, MA
    • Preventive Medicine Section, Boston University, Boston, MA
    • School of Public Health, Boston University, Boston, MA
    • ,
  • Caroline S. Fox, MD, MPH

      Affiliations

    • The National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA
    • National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
    • Brigham and Women's Hospital, Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress correspondence to Caroline S. Fox, MD, MPH, NHLBI's Framingham Heart Study, 73 Mt Wayte Ave, Ste 2, Framingham, MA 01702

Received 26 September 2007 ,Accepted 15 April 2008.

References 

  1. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  3. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–1295
  4. Cheung AK, Sarnak MJ, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study. Kidney Int. 2004;65:2380–2389
  5. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–495
  6. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol. 2002;13:1918–1927
  7. Wheeler DC, Townend JN, Landray MJ. Cardiovascular risk factors in predialysis patients: Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) Study. Kidney Int Suppl. 2003;84:S201–S203
  8. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  9. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149–2155
  10. Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468–1474
  11. Clarkson P, Celermajer DS, Powe AJ, et al. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation. 1997;96:3378–3383
  12. Schachinger V, Britten MB, Elsner M, et al. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation. 1999;100:1502–1508
  13. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation. 2004;109:613–619
  14. Yeboah J, Crouse JR, Hsu FC, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: The Cardiovascular Health Study. Circulation. 2007;115:2390–2397
  15. Vita JA, Keaney JF. Endothelial function: A barometer for cardiovascular risk?. Circulation. 2002;106:640–642
  16. Marin E, Sessa WC. Role of endothelial-derived nitric oxide in hypertension and renal disease. Curr Opin Nephrol Hypertens. 2007;16:105–110
  17. Passauer J, Pistrosch F, Bussemaker E, et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol. 2005;16:959–965
  18. Segarra A, Chacon P, Martinez-Eyarre C, et al. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: Biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol. 2001;12:1255–1263
  19. Mallamaci F, Tripepi G, Cutrupi S, et al. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int. 2005;67:2330–2337
  20. Mallamaci F, Zoccali C, Tripepi G, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002;61:609–614
  21. Buccianti G, Baragetti I, Bamonti F, et al. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol. 2004;17:405–410
  22. London GM, Pannier B, Agharazii M, et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int. 2004;65:700–704
  23. Pannier B, Guerin AP, Marchais SJ, et al. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int. 2000;57:1091–1099
  24. Gris JC, Branger B, Vecina F, et al. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int. 1994;46:807–813
  25. Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189–1197
  26. Jacobson SH, Egberg N, Hylander B, et al. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol. 2002;22:42–47
  27. van GC, Janssen MJ, Lambert J, et al. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant. 1998;13:1782–1786
  28. Morris ST, McMurray JJ, Spiers A, et al. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int. 2001;60:1077–1082
  29. Ghiadoni L, Cupisti A, Huang Y, et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol. 2004;17:512–519
  30. Annuk M, Lind L, Linde T, et al. Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant. 2001;16:302–306
  31. Haaber AB, Eidemak I, Jensen T, et al. Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol. 1995;5:1581–1584
  32. Stam F, van GC, Becker A, et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn Study. J Am Soc Nephrol. 2006;17:537–545
  33. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265
  34. Kannel WB, Feinleib M, McNamara PM, et al. An investigation of coronary heart disease in families (The Framingham Offspring Study). Am J Epidemiol. 1979;110:281–290
  35. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  36. Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:0828A;(abstr)
  37. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  38. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–850
  39. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395–406
  40. Nathan DM, Rosenbaum C, Protasowicki VD. Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care. 1987;10:414–418
  41. Bakker AJ. Detection of microalbuminuria (Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration). Diabetes Care. 1999;22:307–313
  42. Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension. 2004;44:134–139
  43. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation. 2005;111:363–368
  44. Gokce N, Keaney JF, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation. 2002;105:1567–1572
  45. Huang AL, Silver AE, Shvenke E, et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol. 2007;27:2113–2119
  46. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In:  Kannel WB,  Garrison RJ editor. The Framingham Heart Study: An Epidemiologic Investigation of Cardiovascular Disease. Washington DC: Government Printing Office, NIH Publication; 1987;p. 87–203section 34
  47. SAS Institute Inc: Version 8. Cary, NC: SAS Institute; 1999;
  48. Thambyrajah J, Landray MJ, McGlynn FJ, et al. Abnormalities of endothelial function in patients with predialysis renal failure. Heart. 2000;83:205–209
  49. Landray MJ, Wheeler DC, Lip GY, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) Study. Am J Kidney Dis. 2004;43:244–253
  50. Rule AD, Larson TS, Bergstralh EJ, et al. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141:929–937
  51. Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes. 2002;51:1157–1165
  52. Nelson CL, Karschimkus CS, Dragicevic G, et al. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant. 2005;20:2420–2426

 Originally published online as doi:10.1053/j.ajkd.2008.04.027 on July 10, 2008.

 E.J.B. and C.S.F. contributed equally to this work.

PII: S0272-6386(08)00887-1

doi: 10.1053/j.ajkd.2008.04.027

American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 859-867 , November 2008

Article Tools